14 November 2003 in Journal of Combinatorial Chemistry
1 November 2021 in Bioorganic Chemistry
18 January 2024 in Bioconjugate Chemistry
N-Boc-N-(2-(tritylthio)ethoxy)glycine has been developed as a building block for peptide ubiquitination, which is fully compatible with solid-phase Fmoc chemistry and common peptide modifications including phosphorylation, methylation, acetylation, biotinylation, and fluorescence labeling. The optimal conditions for peptide cleavage and auxiliary removal were obtained. The utility of this building block in peptide ubiquitination was demonstrated by the synthesis of seven ubiquitinated histone and Tau peptides bearing various modifications. Cys residues were well tolerated and did not require orthogonal protection. The structural integrity and folding of the synthesized ubiquitinated peptides were confirmed by enzymatic deubiquitination of a fluorescently labeled ubiquitin conjugate. The synthetic strategy using this building block provides a practical approach for the preparation of ubiquitinated peptides with diverse modifications.
10 September 2026 in Science
T cell receptor (TCR) engagement stimulates formation of a biomolecular condensate, including the scaffold protein linker of activated T cells (LAT). We investigated whether the immune-inhibitory receptor programmed cell death protein 1 (PD-1) inhibits by impeding TCR-induced LAT condensation. In vitro reconstitutions revealed that the cytoplasmic domain of PD-1 directly inhibited LAT condensation. This inhibitory interaction required tyrosine residues in the two inhibitory motifs of PD-1. Contrary to current working models, tyrosine phosphorylation eliminated PD-1 inhibition. Replacing tyrosine with tryptophan reconstituted PD-1 inhibition in T cells, confirming that phosphorylation does not mediate this effect. These findings support the concept that hydrogen bond–donating aromatic residues within inhibitory motifs provide the primary mechanism that explains how inhibitory receptors disrupt signaling networks and block immune activation.
9 June 2026 in Journal of Molecular Biology
Neutrophil serine protease 4 (NSP4) is the most ancient member of the NSP family, which includes neutrophil elastase, proteinase 3 and cathepsin G, but is unique in its strong preference for cleavage after an arginine residue. NSP4 is highly expressed in myeloid precursor cells and regulates the levels of vasoactive histamine during mast cell maturation. Neutrophils store active NSP4 in azurophilic granules, but its function in neutrophil biology remains unknown. To advance the understanding of NSP4's biological role, we aimed to generate potent and selective inhibitors by using large mRNA-displayed libraries each encoding up to 1013 unique macrocyclic peptides (MCPs) containing both natural and non-natural amino acids. Library screening yielded six MCPs, which strongly inhibited the activity of recombinant and endogenous cell-derived NSP4, but did not inhibit 13 structurally related proteases. In agreement with biochemical studies with activity-based probes, crystal structures of the two most potent inhibitors MCP-3 and MCP-4 (KD = 6.5 nM and 1.0 nM, respectively) revealed that these MCPs bind to the NSP4 active site region. Remarkably, the two MCPs resembled the plant-derived sunflower trypsin inhibitor-1 in respect to ring conformation, substrate-like interaction with the active site and resistance to hydrolysis. Therefore, these de novo generated MCPs recapitulated the standard mechanism used by natural serine protease inhibitors. This study highlights the power of mRNA-display technology to generate potent and highly selective protease inhibitors, such as the macrocyclic NSP4 inhibitors identified in this work, which serve as valuable tools to study the biological functions of this elusive protease.